Loss of function mutations of phosphatase and tensin homolog (PTEN), a negative regulator of PIK3/AKT/MTOR [68], increase PIK3/AKT/MTOR pathway activation and are associated with cancer development [69]. This evidence concerns the gene AKT1 and cancer.